APA (7th ed.) Citation

Jongh, F. E. d., Efe, R., Herrmann, K. H., & Spoorendonk, J. A. Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands. Wiley.

Chicago Style (17th ed.) Citation

Jongh, Felix E. de, Reva Efe, Kirsten H. Herrmann, and Jelle A. Spoorendonk. Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands. Wiley.

MLA (9th ed.) Citation

Jongh, Felix E. de, et al. Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands. Wiley.